DrugPatentWatch Database Preview
FOSCAVIR Drug Profile
» See Plans and Pricing
Which patents cover Foscavir, and when can generic versions of Foscavir launch?
Foscavir is a drug marketed by Clinigen Hlthcare and is included in one NDA.
The generic ingredient in FOSCAVIR is foscarnet sodium. There are seven drug master file entries for this compound. Additional details are available on the foscarnet sodium profile page.
Summary for FOSCAVIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 60 |
| Clinical Trials: | 7 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FOSCAVIR |
| DailyMed Link: | FOSCAVIR at DailyMed |
Recent Clinical Trials for FOSCAVIR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins Bloomberg School of Public Health | Phase 2/Phase 3 |
| Northwestern University | Phase 2/Phase 3 |
| Icahn School of Medicine at Mount Sinai | Phase 2/Phase 3 |
US Patents and Regulatory Information for FOSCAVIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FOSCAVIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | Start Trial | Start Trial |
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | Start Trial | Start Trial |
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | Start Trial | Start Trial |
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FOSCAVIR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Finland | 772030 | Start Trial |
| United Kingdom | 1585615 | Start Trial |
| Bulgaria | 60834 | Start Trial |
| Austria | 369014 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
